Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

被引：0
|
作者：
Maurizio Fava
Marlene P. Freeman
Martina Flynn
Heidi Judge
Bettina B. Hoeppner
Cristina Cusin
Dawn F. Ionescu
Sanjay J. Mathew
Lee C. Chang
Dan V. Iosifescu
James Murrough
Charles Debattista
Alan F. Schatzberg
Madhukar H. Trivedi
Manish K. Jha
Gerard Sanacora
Samuel T. Wilkinson
George I. Papakostas
机构：
[1] Massachusetts General Hospital,
[2] Baylor College of Medicine/Michael E. Debakey VA Medical Center,undefined
[3] Icahn School of Medicine at Mount Sinai,undefined
[4] Stanford University School of Medicine,undefined
[5] University of Texas Southwestern,undefined
[6] Yale University,undefined
来源：
Molecular Psychiatry | 2020年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Supplementary Figure 1 and Supplementary Tables 1–4 have been re-uploaded so as to reflect the versions supplied during proofs stage. The publisher apologizes for the error in versioning. The HTML version of the paper has been updated.
引用
收藏
页码：1604 / 1604
相关论文
共 50 条
  • [1] Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
    Fava, Maurizio
    Freeman, Marlene P.
    Flynn, Martina
    Judge, Heidi
    Hoeppner, Bettina B.
    Cusin, Cristina
    Ionescu, Dawn F.
    Mathew, Sanjay J.
    Chang, Lee C.
    Iosifescu, Dan V.
    Murrough, James
    Debattista, Charles
    Schatzberg, Alan F.
    Trivedi, Madhukar H.
    Jha, Manish K.
    Sanacora, Gerard
    Wilkinson, Samuel T.
    Papakostas, George I.
    [J]. MOLECULAR PSYCHIATRY, 2020, 25 (07) : 1592 - 1603
  • [2] A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
    Singh, Jaskaran B.
    Fedgchin, Maggie
    Daly, Ella J.
    De Boer, Peter
    Cooper, Kimberly
    Lim, Pilar
    Pinter, Christine
    Murrough, James W.
    Sanacora, Gerard
    Shelton, Richard C.
    Kurian, Benji
    Winokur, Andrew
    Fava, Maurizio
    Manji, Husseini
    Drevets, Wayne C.
    Van Nueten, Luc
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (08): : 816 - 826
  • [3] A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania
    Evins, AE
    Demopulos, C
    Nierenberg, A
    Culhane, MA
    Eisner, L
    Sachs, G
    [J]. BIPOLAR DISORDERS, 2006, 8 (01) : 75 - 80
  • [4] Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial
    Ohtani, Yohei
    Tani, Hideaki
    Nomoto-Takahashi, Kie
    Yatomi, Taisuke
    Yonezawa, Kengo
    Tomiyama, Sota
    Nagai, Nobuhiro
    Kusudo, Keisuke
    Honda, Shiori
    Moriyama, Sotaro
    Nakajima, Shinichiro
    Yamada, Takashige
    Morisaki, Hiroshi
    Iwabuchi, Yu
    Jinzaki, Masahiro
    Yoshimura, Kimio
    Eiro, Tsuyoshi
    Tsugawa, Sakiko
    Ichijo, Sadamitsu
    Fujimoto, Yu
    Miyazaki, Tomoyuki
    Takahashi, Takuya
    Uchida, Hiroyuki
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024,
  • [5] Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
    Yonezawa, Kengo
    Uchida, Hiroyuki
    Yatomi, Taisuke
    Ohtani, Yohei
    Nomoto-Takahashi, Kie
    Nakajima, Shinichiro
    Mimura, Masaru
    Tani, Hideaki
    [J]. PHARMACOPSYCHIATRY, 2024, 57 (01) : 35 - 40
  • [6] A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Dose Frequency Study of Intravenous Ketamine in Patients with Treatment-Resistant Depression
    Singh, Jaskaran
    Fedgchin, Maggie
    Daly, Ella
    De Boer, Peter
    Cooper, Kimberly
    Lim, Pilar
    Pinter, Christine
    Murrough, James
    Sanacora, Gerard
    Shelton, Richard
    Kurian, Benji
    Winokur, Andrew
    Fava, Maurizio
    Manji, Husseini
    Drevets, Wayne
    Van Nueten, Luc
    [J]. BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 44S - 44S
  • [7] Onset of efficacy of ketamine in treatment-resistant depression: a double-blind, randomised, placebo-controlled, dose frequency study
    Singh, J.
    Fedgchin, M.
    Daly, E.
    De Boer, P.
    Cooper, K.
    Lim, P.
    Pinter, C.
    Murrough, J.
    Sanacora, G.
    Shelton, R.
    Kurian, B.
    Winokur, A.
    Fava, M.
    Manji, H.
    Drevets, W.
    Van Nueten, L.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S387 - S388
  • [8] Rituximab in rheumatoid arthritis: A double-blind, placebo-controlled, dose-ranging trial.
    Emery, P
    Fleischmann, RM
    Filipowicz-Sosnowska, A
    Schechtman, J
    Ramos-Remus, C
    Gomez-Reino, JJ
    Hessey, EW
    Shaw, TM
    Li, NF
    Agarwal, S
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S709 - S709
  • [9] A double-blind, dose-ranging, placebo-controlled trial of L-arginine for PAD
    Oka, RK
    Szuba, A
    Giacomini, JC
    Kapoor, O
    Soltani, A
    Bene, G
    Cooke, JP
    [J]. CIRCULATION, 2002, 106 (19) : 741 - 741
  • [10] Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
    Singh, Jaskaran B.
    Fedgchin, Maggie
    Daly, Ella
    Xi, Liwen
    Melman, Caroline
    De Bruecker, Geert
    Tadic, Andre
    Sienaert, Pascal
    Wiegand, Frank
    Manji, Husseini
    Drevets, Wayne C.
    Van Nueten, Luc
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 80 (06) : 424 - 431
12345